Nanoparticles and Biomaterials: Pioneering Innovations in Biomedical Device Engineering

Dear Colleagues,

The upcoming Special Issue of Biomedicine, entitled “Nanoparticles and Biomaterials: Pioneering Innovations in Biomedical Device Engineering”, will focus on the integration of nanoparticles NPs and biomaterials with innovative approaches for the treatment of degenerative disorders, targeting disease treatments and tissue regeneration. Additionally, we will concentrate on the antimicrobial activity of nanoparticles and prospects for the future.  

As alternatives to antibiotics, nanoparticles (NPs) are increasingly being employed to target bacteria. The application of NPs in antimicrobial coatings for biomedical devices is one such example; others include the use of antibiotic delivery methods to treat illness, the application of bacterial detection systems to produce microbial diagnostics, the administration of antibacterial vaccinations to prevent bacterial infections, and the design of pharmaceutical materials to prevent infection and encourage wound healing. This Special Issue focuses on NPs’ antibacterial activity, oxidative stress induction, metal ion release, and non-oxidative mechanisms.

In medicine and biology, the actions of NPs are of great interest for their antibacterial activity and effective action against cancer cells, their anti-inflammatory action, the use of their chemiluminescent properties in bioimaging, their ability to accelerate wound healing, and their anti-diabetic properties.

Innovative biomedical devices use nanoparticles that are attached to protein mRNAs in order to signal inside cells for either disease treatment or targeted differentiation.

This Special Issue is open for the submission of basic and clinical research, or studies adopting a multi-disciplinary approach, and will also include original articles and reviews on the following topics:

• Novel nanoparticles, including biomedical devices.
• Biomaterials-based mesenchymal stem cell therapy.
• Bioactive-biomaterials signal delivery for mesenchymal stem cell differentiation.
• Application of biomedical applications in osteogenesis, chondrogenesis, angiogenesis, neurogenesis, etc.
• Clinical trials/research on biomedical devices and NPs.
• Tissue engineering.
• Cancer.
• mRNAs delivery through NPs.

Dr. Eleni Papachristou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.